PNC Financial Services Group Inc. Reduces Stock Position in The Cooper Companies, Inc. $COO

PNC Financial Services Group Inc. trimmed its position in The Cooper Companies, Inc. (NASDAQ:COO) by 17.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 64,736 shares of the medical device company’s stock after selling 13,466 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Cooper Companies were worth $4,438,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. CYBER HORNET ETFs LLC acquired a new position in Cooper Companies in the 2nd quarter worth approximately $36,000. MUFG Securities EMEA plc acquired a new stake in Cooper Companies during the 2nd quarter valued at approximately $42,000. Assetmark Inc. increased its stake in shares of Cooper Companies by 357.8% in the second quarter. Assetmark Inc. now owns 618 shares of the medical device company’s stock worth $44,000 after acquiring an additional 483 shares during the period. Quent Capital LLC acquired a new stake in shares of Cooper Companies in the third quarter worth $44,000. Finally, Mather Group LLC. purchased a new position in shares of Cooper Companies during the third quarter worth $56,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Price Performance

NASDAQ:COO opened at $84.07 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30. The Cooper Companies, Inc. has a 52 week low of $61.78 and a 52 week high of $92.84. The stock’s 50-day moving average price is $82.12 and its 200-day moving average price is $75.21. The stock has a market capitalization of $16.48 billion, a PE ratio of 44.72, a price-to-earnings-growth ratio of 2.39 and a beta of 1.03.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. The company had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.Cooper Companies’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.04 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. As a group, equities analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Insider Transactions at Cooper Companies

In related news, Director Lawrence Erik Kurzius purchased 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 17th. The stock was bought at an average price of $82.50 per share, with a total value of $165,000.00. Following the acquisition, the director owned 7,777 shares in the company, valued at $641,602.50. The trade was a 34.62% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Albert G. White III acquired 10,000 shares of Cooper Companies stock in a transaction on Tuesday, December 16th. The shares were bought at an average price of $80.80 per share, with a total value of $808,000.00. Following the completion of the transaction, the chief executive officer directly owned 236,151 shares of the company’s stock, valued at $19,081,000.80. This trade represents a 4.42% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired 16,014 shares of company stock worth $1,304,416 in the last ninety days. Company insiders own 1.98% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on COO shares. JPMorgan Chase & Co. upped their price target on shares of Cooper Companies from $66.00 to $78.00 and gave the company a “neutral” rating in a report on Friday, December 5th. Weiss Ratings raised Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 12th. Barclays set a $98.00 target price on Cooper Companies and gave the stock an “overweight” rating in a report on Monday, January 26th. William Blair upgraded Cooper Companies to a “strong-buy” rating in a research report on Friday, January 30th. Finally, Wells Fargo & Company upped their price objective on Cooper Companies from $72.00 to $82.00 and gave the stock an “equal weight” rating in a research report on Friday, December 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and an average price target of $90.77.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.